{"id":801157,"date":"2025-01-15T12:04:03","date_gmt":"2025-01-15T17:04:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/"},"modified":"2025-01-15T12:04:03","modified_gmt":"2025-01-15T17:04:03","slug":"kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/","title":{"rendered":"Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">LOS ANGELES<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Jan. 15, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4341001-1&amp;h=308265192&amp;u=https%3A%2F%2Fwww.frankcruzlaw.com%2F&amp;a=The+Law+Offices+of+Frank+R.+Cruz\" target=\"_blank\" rel=\"nofollow\">The Law Offices of <span class=\"xn-person\">Frank R. Cruz<\/span><\/a> announces that investors with losses related to Kyverna Therapeutics, Inc. (&#8220;Kyverna&#8221; or the &#8220;Company&#8221;) (NASDAQ: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4341001-1&amp;h=3967572129&amp;u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2Fkytx&amp;a=KYTX\" target=\"_blank\" rel=\"nofollow\">KYTX<\/a>) have opportunity to lead the securities <span>fraud<\/span> class action lawsuit.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1221557\/The_Law_Offices_of_Frank_R_Cruz_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1221557\/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg\" title=\"(PRNewsfoto\/The Law Offices of Frank R. Cru)\" alt=\"(PRNewsfoto\/The Law Offices of Frank R. Cru)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p class=\"prntac\">\n        <b>IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN KYVERNA THERAPEUTICS, INC. (KYTX), CLICK\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4341001-1&amp;h=3688163465&amp;u=https%3A%2F%2Fwww.frankcruzlaw.com%2Fcases%2Fkyverna-therapeutics-inc%2F&amp;a=HERE\" target=\"_blank\" rel=\"nofollow\">HERE<\/a>\u00a0BEFORE <span class=\"xn-chron\">FEBRUARY 7, 2025<\/span> (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES <span>FRAUD<\/span> LAWSUIT.<\/b>\n      <\/p>\n<p>\n        <b>What Is The Lawsuit About?\u00a0<br \/><\/b>The complaint filed <span>alleges<\/span> that, pursuant and\/or traceable to the Registration Statement issued in connection with the Company&#8217;s <span class=\"xn-chron\">February 2024<\/span> initial public offering, Defendants failed to disclose to investors: (1) adverse data it possessed related to one of its trials; (2) the risk posed by the Company&#8217;s withholding of adverse data regarding one of its clinical trials; and (3) as a result, Defendants&#8217; positive statements about the Company&#8217;s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis at all relevant times.<\/p>\n<p>\n        <b>Contact Us To Participate or Learn More: <\/b>\n      <\/p>\n<p>If you wish to\u202flearn more\u202fabout this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. <br \/>The Law Offices of Frank R. Cruz,\u00a0 <br \/>Email us at: <a href=\"mailto:info@frankcruzlaw.com\" target=\"_blank\" rel=\"nofollow\">info@frankcruzlaw.com<\/a><br \/>Call us at: 310-914-5007<br \/>Visit our website at: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4341001-1&amp;h=3583126890&amp;u=https%3A%2F%2Fwww.frankcruzlaw.com%2F&amp;a=www.frankcruzlaw.com\" target=\"_blank\" rel=\"nofollow\">www.frankcruzlaw.com<\/a><br \/>Follow us for updates on Twitter: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4341001-1&amp;h=4026406728&amp;u=https%3A%2F%2Ftwitter.com%2FFRC_LAW&amp;a=twitter.com%2FFRC_LAW\" target=\"_blank\" rel=\"nofollow\">twitter.com\/FRC_LAW<\/a>.<\/p>\n<p>If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.<\/p>\n<p>To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. \u00a0<\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p>\n        <b>Contact Us: : <\/b>The Law Offices of <span class=\"xn-person\">Frank R. Cruz<\/span>, Los Angeles,\u00a0Frank R. Cruz,,\u00a0Telephone: 310-914-5007,,\u00a0Email: <a href=\"mailto:fcruz@frankcruzlaw.com\" target=\"_blank\" rel=\"nofollow\">fcruz@frankcruzlaw.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA96704&amp;sd=2025-01-15\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302351374.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302351374.html<\/a><\/p>\n<p>SOURCE  The Law Offices of <span class=\"xn-person\">Frank R. Cruz<\/span>, <span class=\"xn-location\">Los Angeles<\/span><\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA96704&amp;Transmission_Id=202501151200PR_NEWS_USPR_____LA96704&amp;DateId=20250115\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire LOS ANGELES , Jan. 15, 2025 \/PRNewswire\/ &#8212; The Law Offices of Frank R. Cruz announces that investors with losses related to Kyverna Therapeutics, Inc. (&#8220;Kyverna&#8221; or the &#8220;Company&#8221;) (NASDAQ: KYTX) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN KYVERNA THERAPEUTICS, INC. (KYTX), CLICK\u00a0HERE\u00a0BEFORE FEBRUARY 7, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. What Is The Lawsuit About?\u00a0The complaint filed alleges that, pursuant and\/or traceable to the Registration Statement issued in connection with the Company&#8217;s February 2024 initial public offering, Defendants failed to disclose to investors: (1) adverse data it possessed related to one of its trials; (2) the risk &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-801157","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire LOS ANGELES , Jan. 15, 2025 \/PRNewswire\/ &#8212; The Law Offices of Frank R. Cruz announces that investors with losses related to Kyverna Therapeutics, Inc. (&#8220;Kyverna&#8221; or the &#8220;Company&#8221;) (NASDAQ: KYTX) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN KYVERNA THERAPEUTICS, INC. (KYTX), CLICK\u00a0HERE\u00a0BEFORE FEBRUARY 7, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. What Is The Lawsuit About?\u00a0The complaint filed alleges that, pursuant and\/or traceable to the Registration Statement issued in connection with the Company&#8217;s February 2024 initial public offering, Defendants failed to disclose to investors: (1) adverse data it possessed related to one of its trials; (2) the risk &hellip; Continue reading &quot;Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-15T17:04:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1221557\/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit\",\"datePublished\":\"2025-01-15T17:04:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\\\/\"},\"wordCount\":361,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1221557\\\/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\\\/\",\"name\":\"Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1221557\\\/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg\",\"datePublished\":\"2025-01-15T17:04:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1221557\\\/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1221557\\\/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/","og_locale":"en_US","og_type":"article","og_title":"Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Market Newsdesk","og_description":"PR Newswire LOS ANGELES , Jan. 15, 2025 \/PRNewswire\/ &#8212; The Law Offices of Frank R. Cruz announces that investors with losses related to Kyverna Therapeutics, Inc. (&#8220;Kyverna&#8221; or the &#8220;Company&#8221;) (NASDAQ: KYTX) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN KYVERNA THERAPEUTICS, INC. (KYTX), CLICK\u00a0HERE\u00a0BEFORE FEBRUARY 7, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. What Is The Lawsuit About?\u00a0The complaint filed alleges that, pursuant and\/or traceable to the Registration Statement issued in connection with the Company&#8217;s February 2024 initial public offering, Defendants failed to disclose to investors: (1) adverse data it possessed related to one of its trials; (2) the risk &hellip; Continue reading \"Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-15T17:04:03+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1221557\/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit","datePublished":"2025-01-15T17:04:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/"},"wordCount":361,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1221557\/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/","name":"Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1221557\/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg","datePublished":"2025-01-15T17:04:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1221557\/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1221557\/The_Law_Offices_of_Frank_R_Cruz_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyverna-therapeutics-inc-kytx-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/801157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=801157"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/801157\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=801157"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=801157"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=801157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}